Skip to main content
. 2017 Sep 20;14(12):1241–1250. doi: 10.7150/ijms.20618

Table 3.

Long-term outcomes of the survivors from acute myocarditis

Variable Number of events (%) Adjusted hazard ratio and 95% CI‡
Non-MCS
(n = 780)
IABP
(n = 80)
ECMO
(n = 119)
IABP vs. Non-MCS ECMO vs. non-MCS ECMO vs. IABP
HR (95% CI) P HR (95% CI) P HR (95% CI) P
Primary outcomes
HF hospitalization* 65 (8.3) 5 (6.3) 10 (8.4) 0.58 (0.23, 1.46) 0.248 0.69 (0.34, 1.40) 0.303 1.18 (0.39, 3.56) 0.767
HF hospitalization within 3 months* 20 (2.6) 3 (3.8) 2 (1.7) 1.56 (0.48, 5.06) 0.462 0.44 (0.09, 2.15) 0.311 0.28 (0.05, 1.70) 0.168
HF hospitalization after 3 months* 45 (5.8) 2 (2.5) 8 (6.7) 0.27 (0.06, 1.20) 0.085 1.18 (0.49, 2.82) 0.716 4.43 (0.85, 23.19) 0.078
CV death 101 (12.9) 8 (10.0) 26 (21.8) 1.42 (0.90, 2.24) 0.136 3.88 (2.93, 5.12) <0.001 2.74 (1.70, 4.40) <0.001
CV death within 3 months 32 (4.1) 4 (5.0) 19 (16.0) 2.39 (1.41, 4.05) 0.001 5.28 (3.79, 7.36) <0.001 2.21 (1.31, 3.74) 0.003
CV death after 3 months 69 (8.8) 4 (5.0) 7 (5.9) 0.52 (0.19, 1.45) 0.213 1.04 (0.50, 2.14) 0.924 1.98 (0.60, 6.55) 0.262
All-cause mortality 197 (25.3) 12 (15.0) 32 (26.9) 0.53 (0.30, 0.97) 0.038 1.42 (0.96, 2.10) 0.084 2.65 (1.35, 5.20) 0.005
Mortality within 3 months 86 (11.0) 4 (5.0) 22 (18.5) 0.50 (0.18, 1.38) 0.179 2.01 (1.22, 3.30) 0.006 4.03 (1.37, 11.84) 0.011
Mortality after 3 months 111 (14.2) 8 (10.0) 10 (8.4) 0.53 (0.26, 1.11) 0.090 0.87 (0.44, 1.73) 0.690 1.64 (0.63, 4.26) 0.310
Secondary outcomes
Long-term dialysis 10 (1.3) 0 (0.0) 0 (0.0) NA NA NA NA NA NA
VT/VF 10 (1.3) 0 (0.0) 1 (0.8) NA NA 0.24 (0.02-2.28) 0.214 NA NA
Stroke 28 (3.6) 0 (0.0) 1 (0.8) NA NA 0.34 (0.04-2.66) 0.303 NA NA

Abbreviation: CV death: cardiovascular death; HF: heart failure, VT/VF: ventricular tachycardia/ventricular fibrillation

HR: hazard ratio; CI: confidence interval; ECMO: extracorporeal membrane oxygenation; IABP: intra-aortic balloon pump; MCS: mechanical circulation support;